🇺🇸 FDA
Pipeline program

TRV734

999920014

Phase 2 small_molecule completed

Quick answer

TRV734 for Opioid-Use Disorder is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Opioid-Use Disorder
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials